These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
519 related items for PubMed ID: 11590147
1. Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27(Kip1) association with cyclin E-Cdk2. Musgrove EA, Hunter LJ, Lee CS, Swarbrick A, Hui R, Sutherland RL. J Biol Chem; 2001 Dec 14; 276(50):47675-83. PubMed ID: 11590147 [Abstract] [Full Text] [Related]
2. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells. Hui R, Finney GL, Carroll JS, Lee CS, Musgrove EA, Sutherland RL. Cancer Res; 2002 Dec 01; 62(23):6916-23. PubMed ID: 12460907 [Abstract] [Full Text] [Related]
3. Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells. Swarbrick A, Lee CS, Sutherland RL, Musgrove EA. Mol Cell Biol; 2000 Apr 01; 20(7):2581-91. PubMed ID: 10713180 [Abstract] [Full Text] [Related]
4. Mechanisms of cyclin-dependent kinase inactivation by progestins. Musgrove EA, Swarbrick A, Lee CS, Cornish AL, Sutherland RL. Mol Cell Biol; 1998 Apr 01; 18(4):1812-25. PubMed ID: 9528753 [Abstract] [Full Text] [Related]
5. ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency. Lane HA, Beuvink I, Motoyama AB, Daly JM, Neve RM, Hynes NE. Mol Cell Biol; 2000 May 01; 20(9):3210-23. PubMed ID: 10757805 [Abstract] [Full Text] [Related]
6. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors. Salatino M, Labriola L, Schillaci R, Charreau EH, Elizalde PV. Exp Cell Res; 2001 Apr 15; 265(1):152-66. PubMed ID: 11281653 [Abstract] [Full Text] [Related]
13. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip). Chen WJ, Chang CY, Lin JK. Biochem Pharmacol; 2003 Jun 01; 65(11):1777-85. PubMed ID: 12781329 [Abstract] [Full Text] [Related]
16. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes. Nahum A, Hirsch K, Danilenko M, Watts CK, Prall OW, Levy J, Sharoni Y. Oncogene; 2001 Jun 07; 20(26):3428-36. PubMed ID: 11423993 [Abstract] [Full Text] [Related]
18. Inhibition of MCF-7 breast cancer cell proliferation by 5alpha-dihydrotestosterone; a role for p21(Cip1/Waf1). Greeve MA, Allan RK, Harvey JM, Bentel JM. J Mol Endocrinol; 2004 Jun 07; 32(3):793-810. PubMed ID: 15171713 [Abstract] [Full Text] [Related]
19. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells. Di Gennaro E, Barbarino M, Bruzzese F, De Lorenzo S, Caraglia M, Abbruzzese A, Avallone A, Comella P, Caponigro F, Pepe S, Budillon A. J Cell Physiol; 2003 Apr 07; 195(1):139-50. PubMed ID: 12599217 [Abstract] [Full Text] [Related]
20. A low abundance pool of nascent p21WAF1/Cip1 is targeted by estrogen to activate cyclin E*Cdk2. Prall OW, Carroll JS, Sutherland RL. J Biol Chem; 2001 Nov 30; 276(48):45433-42. PubMed ID: 11581254 [Abstract] [Full Text] [Related] Page: [Next] [New Search]